Overview

Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis

Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study aims to discuss the efficacy and safety of neoadjuvant chemotherapy with XELOX regimen (oxaliplatin plus capecitabine) .
Phase:
Phase 3
Details
Lead Sponsor:
Peking University People's Hospital
Collaborators:
Peking University
Sanofi
Treatments:
Capecitabine
Liver Extracts
Oxaliplatin